# Advisor Review - GPT-5.2

**Role:** Academic advisor checking for fatal errors
**Model:** openai/gpt-5.2
**Paper:** paper.pdf
**Timestamp:** 2026-02-24T17:40:05.162028
**Route:** OpenRouter + LaTeX
**Paper Hash:** f6b597afed190bc9
**Tokens:** 23011 in / 1185 out
**Response SHA256:** 0e0f3c42aae72da5

---

No fatal errors found in the four categories you specified.

### Checks performed (fatal-error scan)

**1) Data–Design Alignment (critical)**  
- **Treatment timing vs data coverage:** Treatment is April 2020 peak stringency; your outcome panel spans **Jan 2018–Sep 2024 (excluding Mar 2020)**, so treatment lies inside the data window and there is ample pre/post coverage.  
- **Post-treatment observations:** Yes. Post period is April 2020 onward through Sep 2024.  
- **Treatment definition consistency:** “Peak April 2020 stringency (rescaled to [0,1]) × HCBS × Post” is consistently described in text and in Table 3 (main DDD) and robustness table.

**2) Regression Sanity (critical)**  
Scanned all reported regression tables for impossible/implausible output.  
- No **NA/NaN/Inf** entries.  
- No negative SEs; no R² outside [0,1] (R² not reported, which is fine).  
- Coefficient magnitudes for log outcomes are not mechanically impossible (all well below 10 in absolute value).  
- Standard errors are not explosively large (none remotely near the “SE > 100 × |coef|” red-flag threshold).

**3) Completeness (critical)**  
- Regression tables report **standard errors** and **sample sizes (N/Observations)**.  
- No placeholders (“TBD/TODO/XXX/NA”) in tables.  
- Tables and figures cited in the main text appear to have corresponding LaTeX environments (e.g., main DDD table, decomposition table, robustness table, event-study figure, period-effects figure, appendix period table, HCPCS appendix table).

**4) Internal Consistency (critical)**  
- Sample period accounting is internally consistent: Jan 2018–Sep 2024 is 81 months; excluding Mar 2020 yields **80 months**, matching the paper’s “80 months” and the 51×2×80 ≈ 8,100 observation counts.  
- Main-regression observation count change (8,099 raw → 8,038 effective) is consistently explained by singleton absorption.  
- OxCGRT coverage ending Dec 2022 is handled consistently (main treatment is time-invariant April 2020 peak; the one time-varying monthly stringency check is restricted to Apr 2020–Dec 2022).

ADVISOR VERDICT: PASS